Genmab A/S (NASDAQ:GMAB) Q3 2023 Earnings Call Transcript November 7, 2023
Genmab A/S beats earnings expectations. Reported EPS is $0.47, expectations were $0.34.
Operator: Hello, and welcome to Genmab’s Third Quarter 2023 Financial Results Conference Call. As a reminder, this conference call is being recorded. During this telephone conference, you may be presented with forward-looking statements that include words such as believes, anticipates, plans, or expects. Actual results may differ...
